AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Elbit Imaging-M Ltd.

Foreign Filer Report Aug 19, 2016

6760_rns_2016-08-18_7a5e9729-60f3-4cff-9225-1861340f8e4a.pdf

Foreign Filer Report

Open in Viewer

Opens in native device viewer

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2016

Commission File Number 000-28996

ELBIT IMAGING LTD.

(Translation of Registrant's Name into English)

7 MOTA GUR STREET, PETACH TIKVA 4900102 (Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40- F.

Form 20-F☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ☐ No ☒

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-_

Attached hereto and incorporated by reference herein are the following documents:

  • 99.1 Operating and Financial Review and Prospects for the six-month period ended June 30, 2016.
  • 99.2 Unaudited Interim Consolidated Financial Data for the six-month period ended June 30, 2016.

Exhibits 99.1 and 99.2 of this Report on Form 6-K are hereby incorporated by reference into Elbit Imaging Ltd.'s Registration Statement on Form F-3 (Registration Statement No. 333-172122) and Registration Statements on Form S-8 (Registration Statements Nos. 333-117509, 333-130852, 333-136684 and 333-152820) and to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

ELBIT IMAGING LTD. (Registrant)

Date: August 18, 2016

By: /s/ Ron Hadassi

—————————————— Ron Hadassi Chairman of the Board

EXHIBIT INDEX

EXHIBIT NO. DESCRIPTION

  • 99.1. Operating and Financial Review and Prospects for the six-month period ended June 30, 2016.
  • 99.2. Unaudited Interim Consolidated Financial Data for the six-month period ended June 30, 2016.

Operating and Financial Review and Prospects

The activities of Elbit Imaging Ltd. ("Elbit" or the "Company") are divided into the following principal fields: (i) Commercial Centers - initiation, construction and sale of commercial centers and other mixed-use real property projects, predominantly in the retail sector, located in Central and Eastern Europe, primarily through our 45% subsidiary Plaza Centers N.V. ("PC); in certain circumstances and depending on market conditions, we operate and manage commercial centers prior to their sale; (ii) Hotel - hotel operation and management; (iii) Medical Industries - (a) research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment and (b) development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine; and (iv) Plots in India - plots designated for sale which were initially designated to residential projects

We may from time to time make written or oral forward-looking statements, including in filings with the U.S. Securities and Exchange Commission ("SEC"), in reports to shareholders, press releases and investor webcasts. Forward-looking statements include statements regarding the intent, belief or current expectations of Elbit and our management about our business, financial condition, results of operations, and our relationship with our employees and the condition of our properties. Words such as "believe", "expect," "intend", "estimate" and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Actual results may differ materially from those projected, expressed or implied in the forward-looking statements as a result of various factors including, without limitation, the factors set forth in our filings with the SEC including, without limitation, Item 3.D of our Annual Report on Form 20-F for the fiscal year ended December 31, 2015, under the caption "Risk Factors". Any forward-looking statements speak only as of the date of such statement, and we caution existing and prospective investors not to place undue reliance on such statements. Such forward-looking statements do not purport to be predictions of future events or circumstances, and therefore, there can be no assurance that any forward-looking statement will prove to be accurate. We undertake no obligation to update or revise any forward-looking statements.

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the unaudited interim consolidated financial data for the period ended June 30, 2016 included elsewhere in this Current Report on Form 6-K and in conjunction with our consolidated financial statements and the related notes and other financial information included in our Annual Report on Form F-20 submitted to the SEC on April 21, 2016.

Six months ended June 30, 2016 compared to corresponding period in 2015

Consolidated income and revenues for the six months' period ended June 30, 2016 amounted to NIS 219 million (\$ 57 million) compared to NIS 312 million in the corresponding period in 2015. Following is the analyses of our revenues:

  • (i) Revenues from sale of commercial centers decreased in the first half of 2016 to NIS 116 million (\$ 30 million) compared to NIS 182 million in the corresponding period. Such amount in 2016 was attributable to the sale of Liberce Plaza commercial centers in Czech Republic and the sale of plots in Belgrade, Romania and Poland by PC. The revenues in 2015 is attributed mainly to the sale of the Koregaon Park in Pune, India.
  • (ii) Revenues from hotel operations and management amounted to NIS 67 million (\$17 million) in the first half of 2016 compared to NIS 85 million in the corresponding period. The decrease was mainly attributable to the sale of our hotels in Antwerp, Belgium in May 2015 partially offset by an increase in the revenue of the Radisson Blu Hotel in Bucharest Romania. The average occupancy rate in our hotels was approximately 78% in 2016 compared to 80% in 2015, and the average room rate was approximately €93 in 2015 and in 2016. Our hotels consist approximately of 764 rooms in 2016 and 990 rooms in 2015.
  • (iii) Rental income from commercial centers amounted to NIS 36 million (\$9 million) in the first half of 2016 compared to NIS 44 million in the corresponding period. The decrease was mainly attributable to the sale of

Liberce commercial center in Q1 2016 and Koregaon Park commercial center in Q2 2015. The average occupancy rates in 2016 were 89%-98% compared to 83%-96% in 2015. PC's business model in respect of its commercial centers is to develop, lease and then sell the properties to third parties. Therefore, the rental income from the commercial centers in the first half of 2016 and 2015 represented only the lease income from the commercial centers and may not be sustainable in the future once PC sells the commercial centers as part of its business cycle.

Expenses and losses (income):

Our expenses and losses in 2016 amounted to NIS 315 million (\$82 million) compared to NIS 518 million in the corresponding period in 2015. Set forth below is an analysis of our expenses and losses:

  • (i) Cost of hotel operations and management amounted to NIS 58 million (\$15 million) in the first half year of 2016 compared to NIS 74 million in the corresponding period. The decrease mainly resulted from the sale of our hotels in Antwerp, Belgium as mentioned above.
  • (ii) Expenses of commercial centers amounted to NIS 130 million (\$34 million) in the first half of 2016 compared to NIS 255 million in the corresponding period in 2015. The decrease was mainly attributable to (i) cost of commercial centers and plots sold by PC during the first half of 2016 in the amount of NIS 105 million (\$28 million) compared to NIS 220 million in the corresponding period (ii) decrease in operational expenses resulting from a decrease in the rental income from commercial centers as mentioned above.
  • (iii) General and administrative expenses decreased to NIS 5 million (\$1 million) in the first half of 2016 compared to NIS 8 million in the corresponding period in 2015. The decrease was mainly attributable to cost saving actions in the Company and its subsidiaries by reducing salaries costs and moving into smaller offices.
  • (iv) Share in losses of associated net amounted to NIS 21 million (\$5 million) in the first half of 2016 compared to NIS 25 million in the corresponding period. Such losses were mainly attributable to losses of INSIGHTEC which is an associate of the Company.
  • (v) Financial expenses, net amounted to NIS 84 million (\$22 million) in the first half of 2016 compared to NIS 181 million in the corresponding period in 2015. The decrease of NIS 97 million related mainly to the following:
    • A decrease in the amount of NIS 86 million (\$23 million) in exchange rate differences mainly attributable to exchange rate differences between the € and NIS on PC's notes, which are recorded in NIS and are measured in €.
    • A decrease in the amount of NIS 13 million (\$3 million) in interest and CPI linked borrowing expenses, net, attributable mainly to a decrease in the Company interest expenses, mainly due to the lower level of corporate debts of the Company following nots buyback programs by the Company.
  • (vi) Write-down, charges and other expenses, net, amounted to NIS 16 million (\$4 million) in the first half of 2016 compared to income in the amount of NIS 25 in the corresponding period in 2015. The amounts in the first half of 2016 include mainly provision in the amount of €2 million (NIS 9 million) as result of arbitration ruling against PC in indemnification claim (see note 9 A) and loses in the amount of NIS 8 due to termination of lease agreement regarding land plot near Tiberius (see note 8 M)
  • (vii) As a result of the foregoing factors, we recognized loss before income tax in the total amount of NIS 96 million (\$25 million) in the first half of 2016 compared to NIS 206 million in the corresponding period in 2015.

Income taxes expenses amounted to NIS 1 million (\$0.2 million) in the first half of 2016 compared to NIS 2 million in the corresponding period in 2015.

The loss from continued operation amounted to NIS 97 million (\$25 million) in the first half a year of 2016 compared to NIS 208 million in the corresponding period.

The profit from discontinued operation amounted to nil in the first half of 2016 compared to NIS 7 million in the corresponding period. The profit in 2015 is mainly attributed to the Company's fashion retail operation, which were sold in January 2015, and accordingly reclassified as discontinued operation.

The above resulted in loss of NIS 97 million (\$25 million) in the first half of 2016, of which NIS 79 million (\$21 million) was attributable to our equity holders and loss in the amount of NIS 17 million (\$4 million) was attributable to the non-controlling interest. The loss in the first half of 2015 amounted to NIS 201 million of which NIS 97 million was attributable to our equity holders and loss in the amount of NIS 104 million was attributable to the non-controlling interest.

(viii) The following table provides supplemental information of our results of operations per segment, for the first half year ended June 30, 2016 (in NIS millions):

Commercial Medical Residential Other and
Segment Hotels Centers Industries Allocations* Total
Revenues 67 116 29 - (29) 183
Rental income from commercial centers - 49 - - (13) 36
Costs and expenses 58 137 87 - (93) 189
Financial expenses (income), net 10 (2) - - - 8
Other expenses, net 7 9 - 1 - 17
Share in losses of associates, net 3 18 21
Segment profit (loss) (8) 21 (61) (1) 33 (16)
Unallocated general and administrative (5)
expenses
Unallocated financial expenses (76)
Unallocated other income 1
Profit before income taxes (96)
Income Tax (1)
Profit from discontinued operation -
Loss for the period (97)

Three months ended June 30, 2016 compared to corresponding period in 2015

Consolidated Income revenues and gains for the three months' period ended June 30, 2016 amounted to NIS 122 million (\$32 million) compared to NIS 244 million in the corresponding period in 2015.

Revenues from hotels operations and management amounted to NIS 37 million (\$10 million) in Q2 2016 compared to NIS 42 million in the corresponding period in 2015. The decrease was mainly attributable to the sale of our hotels in Antwerp, Belgium in May 2015 partially offset by an increase in the revenue of the Radisson Blu Hotel in Bucharest Romania.

Costs and expenses of hotels operations and management amounted to NIS 30 million (\$8 million) in Q2 2016 compared to NIS 34 million in Q2 2015. The decrease resulted from the decrease in the revenue mentioned above.

Revenues from sale of commercial centers amounted to NIS 68 million (\$18 million) in Q2 2016 compared to NIS 182 million in the corresponding period. Such amount in 2016 was attributable to the sale of plot in Belgrade and in 2015 to the sale of the Koregaon Park in Pune India.

Rental income from commercial centers amounted to NIS 17 million (\$4 million) in Q2 2016 compared to NIS 20 million in Q2 2015. The decrease was mainly attributable in the sale of the Koregaon Park commercial center, which was sold in Q2 2015 and in the sale of Liberce commercial center in Q1 2016.

Cost of commercial centers amounted to NIS 70 million (\$18 million) in Q2 2016 compared to NIS 237 million in Q2 2015. The decrease resulted from (i) cost of sale of commercial center and plots sold by PC in the amount of NIS 59 million in Q2 2016 compared to NIS 220 million in Q2 2015 (ii) a decrease in operational expenses resulting from a decrease in the rental income of the commercial center as mentioned above.

General and administrative expenses amounted to NIS 2 million (\$0.5 million) in Q2 2016 compared to NIS 4 million in Q2 2015. The decrease was mainly attributable to cost saving actions in the Company and its subsidiaries by reducing salaries costs and moving into smaller offices.

Share in losses of associated, net amounted to NIS 10 million (\$3 million) in Q2 2016 compared to NIS 11 million and in Q2 2015.

Financial expenses, net amounted to NIS 25 million (\$7 million) in Q2 2016 compared to NIS 57 million in Q2 2015. The decrease of NIS 32 million resulted mainly from a decrease in the amount of NIS 35 million (\$9 million) in interest and CPI- linked borrowing expenses, net, attributable mainly to (i) a decrease in interest expenses in the amount of NIS 18 million (US\$ 5 million) mainly due to cancellation of acceleration of discount amortization in PC's debentures due to changes in the PC forecast cash flow (ii) lower level of corporate debts of the Company and PC following nots buyback programs by the Company and early repayment of debentures by PC .

Write-down and other expenses, net amounted to NIS 16 million (\$4 million) in Q2 2016 compared to income in the amount of NIS 27 million in Q2 2015. The amounts in Q2 2016 include mainly provision in the amount of € 2 million (NIS 9 million) as result of arbitration ruling against PC in indemnification claim (see note 9 A) and loses in the amount of NIS 8 due to termination of lease agreement regarding land plot near Tiberius (see note 8 M)

Loss for the period attributable to equity holders of the Company amounted to NIS 34 million (\$9 million) in Q2 2016 compared to NIS 14 million in Q2 2015. Total loss for the period in Q2 2016 amounted to NIS 31 million (\$ 8 million) compared to NIS 71 million in Q2 2015.

Shareholders' equity as of June 30, 2016 amounted to NIS 220 million (\$57 million) (out of which Shareholders' deficiency in the amount to NIS 47 million (\$12 million) was attributed to the controlling interest.

ELBIT IMAGING LTD. INTERIM CONSOLIDATED FINANCIAL DATA AS OF JUNE 30, 2016

INDEX
Page
Interim Consolidated Balance Sheet 9
Interim Consolidated Income Statements 10-11
Interim Consolidated Comprehensive Income Statements 12
Interim Statement of Changes in Shareholders' Equity 13-14
Interim Consolidated Statements of Cash Flows 15-17
Notes to the condensed consolidated interim financial data 18-31

ELBIT IMAGING LTD. INTERIM CONSOLIDATED BALANCE SHEETS

June 30 December 31 June 30
2 0 1 6
2 0 1 6 2 0 1 5
Convenience
translation
(in NIS thousands) US\$'000
Current Assets
Cash and cash equivalents 157,851 38,525
Short-term deposits and investments 148,166
38,623
30,075 10,042
Trade accounts receivables 14,113 13,638 3,669
Other receivables 26,255 13,909 6,581
Inventories 2,035 2,071 529
Investments in associates held for sale 85,237 - 22,163
314,429 217,544 81,509
Non-Current Assets
Trading property 1,417,770 1,467,760 368,635
Deposits, loans and other long-term balances 37,944 21,899 9.866
Investments in associates 179,938 292,183 46,786
Property, plant and equipment 694,923 704,166 180,687
2,330,575 2,486,008 605,974
2,645,004 2,703,552 687,483
Current Liabilities
Short-term credits 507,346 726,763 131,915
Suppliers and service providers
Payables and other credit balances
25,313
61,860
15,708
63,780
6,336
16,084
594,519 806,251 154,335
Non-Current liabilities
Borrowings 1,671,639 1,443,920 434,644
Other liabilities 73,311 66,530 19,062
Deferred taxes 85,673 82,787 22,275
1,830,623 1,593,237 475,981
Shareholders' Equity (Deficiency)
Attributable to equity holders of the Company (47,199) 19,287 (12,272)
Non controlling Interests 267,061 284,777 69,439
219,862 304,064 57,167
2,645,004 2,703,552 687,483

ELBIT IMAGING LTD. INTERIM CONSOLIDATED INCOME STATEMENTS

Six months ended
June 30
Three months ended
June 30
Year ended
December 31,
Six months
ended
June 30
2 0 1 6 2 0 1 5 2 0 1 6 2 0 1 5 2 0 1 5 2 0 1 6
(in NIS thousands) Convenience
translation
US\$'000
Income revenues and gains
Revenues
Revenues from sale of
commercial centers
115,865 182,315 68,465 182,315 200,078 30,126
Revenues from hotels operation
and management
67,282 85,006 36,505 42,117 147,886 17,494
Total revenues 183,147 267,321 104,970 224,432 347,964 47,620
Gains and other
Rental income from Commercial
centers
36,228 44,443 16,748 19,889 83,849 9,420
Gain from sale investees - - - - 6,712 -
Total income revenues and
gains
219,375 311,764 121,718 244,321 438,525 57,040
Expenses and losses
Hotels operation and
management 57,753 73,503 29,684 34,033 126,849 15,016
Commercial centers 129,987 254,900 69,816 236,946 290,360 33,798
General and administrative
expenses
4,750 8,266 2,153 4,062 16,678 1,235
Share in losses of associates,
net 21,344 25,438 10,444 11,164 42,925 5,550
Financial expenses 84,709 181,043 25,811 56,945 239,580 22,026
Write down, charges and other
expenses(income), net
16,505 (25,368) 15,723 (27,275) 38,298 4,291
315,048 517,783 153,631 315,875 754,690 81,916
Profit (loss) before tax
benefits (95,673) (206,019) (31,913) (71,554) (316,165) (24,876)
Income tax expenses (tax
benefits)
917 2,029 (492) (238) 5,631 238
Profit (loss) from continuing
operations
Profit (loss) from discontinued
(96,590) (208,048) (31,421) (71,316) (321,796) (25,114)
operation, net - 7,229 - 397 6,874 -
Profit (loss)for the period (96,590) (200,819) (31,421) (70,919) (314,922) (25,114)
Attributable to:
Equity holders of the Company (79,329) (96,801) (33,779) (13,718) (186,150) (20,626)
Non controlling interest (17,261) (104,018) 2,358 (57,201) (128,772) (4,488)
(96,590) (200,819) (31,421) (70,919) (314,922) (25,114)

ELBIT IMAGING LTD. INTERIM CONSOLIDATED INCOME STATEMENTS

Six months ended Six months
ended
June 30 December 31, June 30
2 0 1 6 2 0 1 5 2 0 1 5 2 0 1 6
Convenience
(In NIS) Translation \$
Earnings (loss) per share
Basic earnings per share:
From continuing operation (8.63) (11.31) (21) (2.24)
From discontinued operations - 0.78 0.75 -
(8.63) (10.53) (20.25) (2.24)
Diluted earnings per share:
From continuing operation (8.63) (11.31) (21) (2.24)
From discontinued operations - 0.78 0.75 -
(8.63) (10.53) (20.25) (2.24)

ELBIT IMAGING LTD. INTERIM CONSOLIDATED OTHER COMPREHENSIVE INCOME STATEMENT

Six months ended
June 30
Three months ended
June 30
Year ended
December 31,
Six months
ended
June 30
2 0 1 6 2 0 1 5 2 0 1 6 2 0 1 5 2 0 1 5 2 0 1 6
(in NIS thousands) Convenience
translation
US\$'000
Loss for the period (96,590) (200,819) (31,421) (70,919) (314,922) (25,114)
Other comprehensive income
to be reclassified to profit or
loss in subsequent periods:
Exchange differences arising
from translation of foreign
operations (163) (97,317) (1,830) (67,652) (91,319) (42)
Gain (loss) from cash flow
hedge
Reclassification adjustments
relating to foreign operations
(1,248) 713 (2,069) 765 2,081 (325)
disposed of in the period - (32,453) - - (32,454) -
(1,411) (129,057) (3,899) (66,887) (121,692) (367)
Items not to be reclassified to
profit or loss in subsequent
periods:
Revaluations of assets 14,249 16,009 13,455 16,009 83,582 3,705
Other Comprehensive income
(loss)
12,838 (113,048) 9,556 (50,878) (38,110) 3,338
Comprehensive income (loss) (83,752) (313,867) (21,865) (121,797) (353,032) (21,776)
Attributable to:
Equity holders of the Company (66,486) (191,161) (24,164) (72,057) )206,504( (17,287)
Non controlling interests (17,266) )122,706( 2,299 (49,740) (146,528) (4,489)
(83,752) (313,867) (21,865) (121,797) (353,032) (21,776)

ELBIT IMAGING LTD. INTERIM STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY

Share
capital
Share
premium
Other
reserves
(*)
Revaluation
of property,
plant and
equipment
Stock
based
compensati
on reserve
Foreign
currency
translation
reserve
Retained
earnings
Gross
amount
Treasury
stock
Attributable to
shareholders
of
the company
Non
Controlling
interest
Total
shareholders'
equity
(in thousand NIS)
Balance -
January 1, 2015 - 1,055,056 (201,848) 130,549 49,527 (734,176) (67,129) 231,979 - 231,979 481,258 713,237)
Profit (loss) for the year
Other comprehensive
- - - - - - (186,150) (186,150) - (186,150) (128,772) (314,922)
income (loss)
Issuance of shares
Stock based
-
-
-
-
8,007
-
60,783
-
-
-
(109,649)
-
20,504
-
(20,355)
-
-
-
(20,355)
-
(17,756)
-
(38,111)
-
compensation expenses
Treasury stock and old
- - - - 845 - - - - - (175) 670
stock cancellation
Transaction with non
controlling interest
-
-
-
-
-
(148,066)
-
37,413
-
-
-
94,933
-
8,142
845
(7,578)
-
-
845
(7,578)
-
(50,565)
-
(58,143)
Expiration and exercise
of option
Cancelation of
treasury
stock and
old stock
- 50,918 - - 546
(50,918)
- - 546 - 546 787 1,333
Balance -
December 31, 2015
- 1,105,974 (341,907) 228,745 - (748,892) (224,633) 19,287 - 19,287 284,777 304,064
Profit (loss) for the period
Other comprehensive
- - - - - - (79,329) (79,329) - (79,329) (17,261) (96,590)
income (loss)
Stock based
- - (1,226) 7,518 - 84 6,467 12,843 - 12,843 (4) 12,839
compensation expenses
Transaction with non
controlling interest
-
-
-
-
-
(533)
-
533
-
-
-
-
-
-
-
-
-
-
-
-
48
(499)
48
(499)
Balance -
June 30, 2016
- 1,105,974 (343,666) 236,796 - (748,808) (297,495) (47,199) - (47,199) 267,061 219,862

(*) includes transactions with non-controlling interest reserve and hedging reserve.

ELBIT IMAGING LTD. INTERIM STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (CONT.)

Share
capital
Share
premium
Other
reserves
(*)
Revaluation
of property,
plant and
equipment
Stock
based
compensati
on reserve
Foreign
currency
translation
reserve
Retained
earnings
Gross
amount
Treasury
stock
Attributable to
shareholders
of
the company
Non
Controlling
interest
Total
shareholders'
equity
Convenience translation, U.S.\$'000
Balance -
December 31, 2015
- 287,565 (88,899) 59,476 - (194,720) (58,407) 5,015 - 5,015 74,045 79,060
Profit (loss) for the period - - - - - - (20,626) (20,626) - (20,626) (4,488) (25,114)
Other comprehensive
income (loss)
Stock based
- - (319) 1,955 - 22 1,681 3,339 - 3,339 (1) 3,338
compensation expenses
Transaction with non
- - - - - - - - - - 13 13
controlling interest - - (139) 139 - - - - - - (130) (130)
Balance -
June 30, 2016
- 287,565 (89,357) 61,570 - (194,698) (77,352) (12,272) - (12,272) 69,439 57,167

(*) includes transactions with non-controlling interest reserve and hedging reserve.

ELBIT IMAGING LTD. INTERIM CONSOLIDATED STATEMENT OF CASH FLOWS

Six months ended
June 30
Year ended Six months
ended
June 30
December 31,
2 0 1 6 2 0 1 5 2 0 1 5 2 0 1 6
(in NIS thousands) Convenience
Translation
US\$'000
CASH FLOWS FROM OPERATING ACTIVITIES
Profit (loss) for the period from continuing operations (96,590) (208,048) (321,796) (25,114)
Profit from sale of subsidiary (Appendix A) - (4,147) - -
Realization of foreign currency translation reserve in
connection with sale operations - (59,570) - -
Income tax benefit recognized in profit and loss 917 2,029 5,631 238
Finance expenses recognized in profit and loss 84,709 181,044 239,598 22,025
Income tax paid in cash (125) (122) (509) (33)
Depreciation and amortization (including write-down
and impairment)
18,059 51,464 123,145 4,696
Loss (Profit) from realization of investments in
associates and joint venture - - (6,713) -
Share in losses of associates, net 21,344 25,438 42,925 5,550
Loss (Profit) from realization of assets and liabilities 8,174 - (4,872) 2,125
Stock based compensation expenses 58 493 1,047 15
Others 64 (587) (488) 17
Trade accounts receivables (357) 3,379 3,415 (93)
Receivables and other debit balances (24,353) 12,114 10,968 (6,332)
Inventories 56 (94) (118) 15
Trading property and payment on account of trading
property 70,314 232,730 181,680 18,282
Suppliers and service providers 9,780 (2,335) (7,095) 2,543
Payables and other credit balances (545) (57,890) (13,241) (141)
Net cash provided by continuing operations 91,505 175,898 193,367 23,792
Net cash provided (used) by discontinued operating
activities - (2,420) (2,014) -
Net cash provided by operating activities 91,505 173,478 191,353 23,792

ELBIT IMAGING LTD. INTERIM CONSOLIDATED STATEMENT OF CASH FLOWS (Cont.)

Six months ended
June 30
Year ended
December 31,
Six months
ended
June 30
2 0 1 6 2 0 1 5 2 0 1 5 2 0 1 6
(in NIS thousands) Convenience
translation
US\$'000
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from realization of investments in
subsidiaries (Appendix A) - 192,026 192,026 -
Purchase of property plant and equipment, investment
property and other assets (1,359) (9,128) (23,630) (353)
Proceeds from realization of property plant and 38
equipment 145 169 12,916
Investments in associates and joint venture companies - - 76 -
Investments in long-term deposits (14,230) - - (3,700)
Proceed from realization of long-term deposits and
long-term loans
18,492 6,185 10,197 4,808
34
Interest received in cash 129 366 1,404 (2,161)
Short-term deposits and marketable securities, net (8,311) (22,290) 5,070
Net cash provided by continued investing activities (5,134) 167,328 198,059 (1,335)
Net cash provided by discontinued investing activities - 37,737 37,737 -
Net cash provided by investing activities (5,134) 205,065 235,796 (1,335)
CASH FLOWS FROM FINANCING ACTIVITIES:
Purchase of non-controlling interest (499) (62,059) (62,059) (130)
Interest paid in cash (56,561) (69,605) (129,350) (14,706)
Proceeds from long-term borrowings 98,897 - - 25,714
Repayment of long-term borrowings (140,709) (240,276) (377,406) (36,586)
571
Proceeds from selling (purchasing) of derivatives 2,197
-
9,820
(6,997)
(1,610)
(6,997)
-
Proceed from (repayment of) short-term credit
Net cash used in continued financing activities
(96,675) (369,117) (577,422) (25,137)
Net cash provided by (used in) discontinued financing
activities - (2,135) (2,135) -
Net cash used in financing activities (96,675) (371,252) (579,557) (25,137)
Increase in cash and cash equivalents (10,304) 7,291 )152,408( (2,679)
Cash and cash equivalents at the beginning of the
year 157,851 323,182 323,182 41,043
Cash and cash equivalents related to discontinued
operations at the end of the period - (1,057) - -
Net effect on cash due to currency exchange rate
changes
619 (9,581) (12,923) 161
Cash and cash equivalents at the end of the period 148,166 319,835 157,851 38,525

ELBIT IMAGING LTD. INTERIM CONSOLIDATED STATEMENT OF CASH FLOWS (Cont.)

Six months ended
Year ended
June 30
December 31,
2 0 1 6
2 0 1 5
2 0 1 5
Six months
ended
June 30
2 0 1 6
(in NIS thousands) Convenience
translation
Appendix A -
Proceeds from realization of investments in
subsidiaries
US\$'000
Working capital (excluding cash), net - (15,591) (15,591) -
Property, plant equipment and other assets - 203,470 (203,470) -
Profit from realization of subsidiaries - 4,147 (4,147) -
- 192,026 (192,026) -

1. Reporting entity:

  • A. Elbit Imaging Ltd. ("Elbit" or "the Company") was incorporated in 1996 under the laws of the State of Israel. The Company's securities are listed on the NASDAQ Global Select Market (ticker symbol: EMITF) and on the Tel Aviv Stock Exchange ("TASE"). Its executive offices are located at 7 Motta Gur Str., Petach Tikva Israel
  • B. The activities of the Company and its held entities (the "Group") are divided into the following principal fields: (i) Commercial Centers - initiation, construction and sale of commercial centers and other mixed-use real property projects, predominantly in the retail sector, located in Central and Eastern Europe, primarily through its 45% subsidiary Plaza Centers N.V. In certain circumstances and depending on market conditions, the Group operate and manage commercial and entertainment centers prior to their sale; (ii) Hotel - hotel operation and management; (iii) Medical Industries and devices - (a) research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment and (b) development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine; (iv) Plots in India - plots designated for sale initially designated to residential projects.

2. The Company financial position:

The Company's separate financial statements include liabilities to bank Hapoalim and towards Series H and Series I notes, in the aggregate principal amount of approximately NIS 679 million. NIS 128 million (principal plus interest) will become due till the end of 2017 and NIS 351 (principal and interest) will become due in May 2018. In addition, the Company has certain operational expenses for its ongoing operations.

The Company has prepared a projected cash flow until June 2018, which includes the anticipated sources that to the Company's estimation, are expected to serve the repayment of its financial liabilities mentioned above. The main anticipated sources included in the Company's projected cash flow are (i) cash and cash equivalents (on its separate financial statements) of approximately NIS 35 million (ii) net cash expected to be generated from the refinance and the sale of the Company's hotel segment, in the amount of approximately NIS 391 million; and (iii) other sources including the partial sale of shares in our held companies in the medical field and net cash from the sale of our share in the Bangalore project in India as per the Agreement signed on December 2, 2015 in the aggregate amount of approximately NIS 111 million. It should be noted, that the projected cash flow is based on the Company's forward-looking plans, assumptions, estimations, predictions and evaluations which rely on the information known to the Company at the time of the approval of these financial statements (collectively, the "Assumptions"). The materialization, occurrence consummation and execution of the events and transactions and of the Assumptions on which the projected cash flow is based, including with respect to the proceeds and timing thereof, are not certain and are subject to factors beyond the Company's control as well as to the consents and approvals of third parties and certain risks factors. Therefore, delays in the realization of our assets and investments or realization at lower price than expected by us, as well as any other deviation from our Assumptions, could have an adverse effect on our cash flow and our ability to serve our indebtedness on a timely manner.

The Company's Board of directors is of the opinion, based on the projected cash flow and the Assumptions described, that the Company can execute its plans and that it would be able to serve its indebtedness in the foreseeable future.

In light of the foregoing, the Company's board of directors is of the opinion that, the Company is a going concern and hence, the consolidated financial statements of the Company as of June 30, 2016 were prepared based on going concern assumption.

3. Going concern and liquidity position of PC:

The condensed consolidated interim financial information has been prepared on a going concern basis, which assumes that the PC's Group will be able to meet the mandatory repayment terms of banking facilities and its debentures. Following the closing of the pc's restructuring plan ("the Plan" in this note), the PC's condensed consolidated interim financial information included liabilities to bondholder's in the aggregate principal amount of €197 million (NIS 844). The following table sets forth the cash flows forecast of PC until the end of 2017 in order to achieve the abovementioned repayments, as they fall due.

According to the Plan, if until December 1, 2016 the PC manages to repay its principal of debentures in the amount of NIS 434 million (€101 million), then the remaining principal payments shall be deferred for an additional year ("the Deferral"). Since the Plan entered into effect, until June 30, 2016, PC has repaid circa NIS 104 million (€24 million) out of the debentures. The remaining NIS 330 million (€77 million) of the bonds principal (through selling of its assets), together with the interest of approximately €6.5 million (NIS 28) are still to be paid up to December 1, 2016, if PC is to achieve the abovementioned condition in the Plan. Since part of the series B debentures are held in treasury, the total required net principal repayment in 2016 in order to achieve the Deferral is NIS 322 million (€75.2 million).

Achieving this condition depends, to a considerable degree, on the PC's Group's ability to dispose assets and collect cash proceeds of at least of €72 million (NIS 308) by December 1, 2016, as described below.

If PC is unable to achieve the abovementioned Deferral by December 1, 2016, then the mandatory principal repayment and interest due in December 2016, July 2017 and December 2017 will be NIS 84 million (€19.5 million), NIS 135 million (€31.5 million) and NIS 335 million (€78.2 million), respectively. The amounts do not include any 75% mandatory repayment of every sale

As PC's primary objective is to obtain the Deferral, it has therefore reclassified this minimum net amount to current liabilities. The scenario below reflects PC's approved business plan until December 31, 2017:

Expected cash flow (in M €)
In the six
months ending
December 31,
2016
In the year
ending
December 31,
2017
Opening balance of consolidated cash (1) 25 7
Sources of cash during the period
Net proceeds from disposal of operating shopping centers (2) 63 47
Proceeds from disposal of plots held (3) 9 47
Net operating income from shopping centers (4) 6 6
Total sources expected 103 107
Uses of cash during the period
Principal repayment of debentures, net (5) (75) (70)
Interest repayment of debentures, net (7) (7)
Investment in projects under construction (6) (8) (4)
Repayment of bank facilities in subsidiaries (principal +interest) (3) (2)
General and administrative expenses (3) (5)
Total uses expected (96) (88)
Closing balance of consolidated cash (7) 7 19

(1) Opening balance – as appeared in this condensed consolidated interim statement of financial position, including restricted cash (which will be released upon the disposal of the operating shopping centers).

(2) 2016 – Expected net payment from the selling of three shopping centers (Riga, Suwalki and Torun - refer to notes 12(b) and 13(a)). 2017 - expected mainly from the sale of Belgrade Plaza (Visnjicka project)

(3) 2016 - PC expects extensive disposal of it plots held in CEE and in India. Main 2016 disposal are expected in India and Greece. 2017 – Main plots disposal is due to India and Poland.

  • (4) As the operating shopping centers are to be disposed of in 2016, in 2017 Net Operating Income is generated from the Belgrade Plaza (Visnjicka) shopping center to be opened in the first half of 2017.
  • (5) 2016 This reflects the gross amount of €77 million to be paid based on forecast disposal proceeds, net of the expected repayment of debentures series B bonds held in treasury in the amount of €2 million.
  • (6) 2016 Main investment in Belgrade Plaza and in Timisoara project (Romania). 2017 Investment in Timisoara.
  • (7) 2016 Immaterial restricted cash amounts. 2017 Including restricted cash in Visnjicka of €3 million.

3. Going concern and liquidity position of PC: (count.)

It should be noted, that the projected cash flow is based on the PC's forward-looking plans, assumptions, estimations, predictions and evaluations which rely on the information known to PC at the time of the approval of this condensed consolidated interim financial information (collectively, the "Assumptions").

The materialization, occurrence, consummation and execution of the events and transactions and of the assumptions on which the projected cash flow is based, including with respect to the proceeds and timing thereof, although probable, are not certain and are subject to factors beyond PC's control as well as to the consents and approvals of third parties and certain risks factors. Therefore, delays in the realization of PC's assets and investments or realization at lower price than expected by PC's, as well as any other deviation from the PC's Assumptions, could have an adverse effect on PC's cash flows and PC's ability to service its indebtedness in a timely manner.

4. Statement of compliance

This condensed consolidated interim financial information has been prepared in accordance with IAS 34 Interim Financial Reporting. The condensed consolidated interim financial information does not include all of the information required for full annual financial statements, and should be read in conjunction with the annual consolidated financial statements of the Group for the year ended December 31, 2015.

The condensed consolidated interim financial information was approved for issue by the Company's board of directors on August 18, 2016.

Rates of exchange of NIS, in effect, in relation to foreign currency (in NIS) are as follows:

Half year
ended June 30
2016
Year ended
December 31
2015
US Dollar )\$( 3.846 3.902
Euro )€ (
Romanian New Lei (RON)
Indian Rupee (INR)
4.284
0.9476
0.0571
4.247
0.938
0.058

Scope of change in the exchange rate, in effect, of the NIS in relation to the foreign currencies (%):

Half year
ended June 30
2016
Year ended
December 31
2015
US Dollar )\$( (1) 0.3
Euro )€ ( 1 (10)
Romanian New Lei (RON) 1 (11)
Indian Rupee (INR) (2) 5

5. Significant accounting policies

The accounting policies applied by the Group in these condensed interim financial information are the same as those applied by the Group in its latest annual consolidated financial statements as of December 31, 2015.

6. Segment reporting

The chief operating decision-makers (CODM) have been identified as the Chairman of the board CEO and the Acting CEO and CFO. The CODM reviews the Group's internal reporting in order to assess performance and allocate resources. The CODM assess the performance of the Group's segments based on Net Operating Income.

For the purpose of this interim financial information the following business segments were identified:

  • Commercial Centers
  • Hotel
  • Medical industries
  • Plots in India
  • Other activities

6. Segment reporting (Cont.)

Six months period ended June 30, 2016:

Commercial
and
entertainmen
t centers
Hotels Medical
industries (i)
Residential Other
Activities and
allocations
Equity
method
adjustment
Total
( I n t h o u s a n d N I S)
(Unaudited)
Segment revenues 164,617 67,282 28,955 - - (41,479) 219,375
Segment profit (loss) 18,729 1,793 (57,729) (924) - 51,825 13,694
Financial expenses 1,937 (10,196) - - - - (8,259)
Share in losses of associates, net - - (3,239) - - (18,105) (21,344)
Unallocated general and administrative expenses
Unallocated other income
(4,750)
830
Unallocated financial expenses (75,845)
Loss before income taxes (95.673)

(i) Includes mainly investments in associates and therefore not included in the Total Revenues.

6. Segment reporting (Cont.)

Six months' period ended June 30, 2015 :

Commercial
and
entertainmen
t centers
Hotels Medical
industries (i)
Residential Other
Activities and
allocations
Equity
method
adjustment
Total
( I n t h o u s a n d N I S)
(Unaudited)
Segment revenues 239,356 85,006 14,950 - - (27,548) 311,764
Segment profit (loss) (49,797) 68,244 (59,616) (1,395) (2,178) 53,471 8,730
Financial expenses (13,843) (18,438) 1,467 - 30 - (30,784)
Share in losses of associates, net - - (6,574) - - (18,864) (25,438)
Unallocated general and administrative expenses (8,266)
Unallocated financial expenses (150,261)
Profit before income taxes (206,019)

(i) Includes mainly investments in associates and therefore not included in the Total Revenues.

7. Financial instruments

A. Financial risks:

During the six-months period ended June 30, 2016 there have been no significant changes in the Group's financial risk management. Objectives and policies are consistent with those disclosed in note 21.C to the consolidated financial statements as at and for the year ended December 31, 2015.

B. Fair value of financial instruments:

1) The following table presents the book value and fair value of the Group's financial assets (liabilities), which are presented in the financial statements at other than their fair value:

June 30, 2016
Book Value Fair Value
Level (In thousands NIS)
Debentures Level 1 (1.296,954) (1,118,462)
(1.296,954) (1,118,462)
December 31,2015
Book Value Fair Value
Level (In thousands NIS)
Short- term loans at fixed interest rate Level 3 (254,010) (254,010)
Debentures Level 1 (1,324,437) (1,120,926)

8. Significant events during the period

A. Nots buyback programs by the Company:

On, February 1, 2016 the Company's board of directors approved a new program to repurchase up to NIS 40 million (approximately \$10.4 million) of its Series H Notes. The Company purchased NIS 43.4 million par value Series H notes for a total consideration of NIS 40 million.

On May 31, 2016, the company board of directors approved a new program to repurchase up to NIS 40 million (approximately \$10.4 million) of its Series H Notes, commencing the date of this announcement and for a period of 12 months. In accordance with the existing loan agreement with Bank Hapoalim (as amended), the Company will be required to prepay principal amount of approximately NIS 4 million if the Notes buyback will be fully executed. Up through June 30, 2016 the Company purchased NIS 15.8 million par value Series H notes for a total consideration of NIS 14.9 million. The amount of Series H notes purchased by the Company s for June 30, 2016 (including repurchase program published and executed during 2015) is NIS 115.3 million par value for a total consideration of NIS 104.8 million. See also note 9 C.

The Company recorded a profit of NIS 2 million in the period of the six months ended in June 30, 2016

All the notes repurchased have been fully redeemed.

8. Significant events during the period (cont.)

B. Refinancing of the Radisson Blu hotel in Bucharest:

On March 10, 2016 "BUTU" as borrower, Raiffeisen Bank International A.G and Raiffeisen Bank S.A., leading international European banks, as lenders (the "Lenders") and the Company as guarantor have amended and restated the existing facility agreement signed between, among others, BUTU, as borrower, Raiffeisen Bank International A.G, as lender and the Company on 16 September 2011 (the "Existing Facility Agreement"), through an amended and restated facility agreement (the "Amended and Restated Facility Agreement").

According to the Amended and Restated Facility Agreement, the Lenders shall increase the loan to BUTU outstanding under the Existing Facility Agreement up to €97 million (the "New Facility Amount"). The New Facility Amount shall be drawn down in two tranches, with tranche A in the amount of up to €85 million, which BUTU shall be able to utilize until March 31, 2016, and tranche B in the amount of up to €12 million, which BUTU shall be able to utilize starting with September 30, 2016 until June 30, 2017. The utilization of both tranches is subject to the satisfaction of certain conditions precedent as stipulated in the Amended and Restated Facility Agreement.

The proceeds of the New Facility Amount shall be used, inter alia, to refinance certain outstanding loans under the Existing Facility Agreement. The surplus of the New Facility Amount will be used for the repayment of all existing shareholder loans granted to BUTU by Elbit Group.

The principal of the New Facility Amount will be repayable in quarterly instalments and a balloon repayment at 31 December 2020. The New Facility Amount will bear an annual interest of Euribor plus margin of 3.75%, which will be hedged by BUTU in accordance with the provision of the Amended and Restated Facility Agreement.

The New Facility Amount is secured by first rank real estate mortgage on the hotel complex owned by BUTU, security interest over the shares of BUTU and certain other securities stipulated in the Amended and Restated Facility Agreement. In addition, the Company has provided a corporate guarantee to secure the New Facility Amount, whereby the Company guarantees all of BUTU's payment obligations under the Finance Documents (except for the balloon repayment at 31 December 2020).

On March 23, 2016, BUTU has drawn down the first of the two tranches of the loan in the amount of €85 million ("Tranche A"). The amount received by the Company, after the refinance of certain outstanding loans under the original facility agreement, is approximately €24.4 million out of which an amount of €15 million was used for the prepayment of the loan to Bank Hapoalim B.M, as per the amendment to the loan agreement with Bank Hapoalim B.M, as the Company announced on March 22, 2016. (see C below).

C. Amendment to the loan agreement with Bank Hapoalim:

On March 22, 2016 the Company signed on an amendment to the Loan Agreement with Bank Hapoalim B.M. that canceled and replaced the previous loan (the "Amendment" and the "Loan"). According to the new agreement the Company prepaid the Bank €15 million and the following new terms were apply to the loan:

  • (1) The repayment schedule of the loan will be as follow: €7 million will be repaid on November 30, 2016 and the balance will be repaid on November 30, 2017 instead of one single payment in February 20, 2017 in the existing Loan Agreement.
  • (2) The Company will not have prepayment obligation for notes repurchase which will be executed by the Company during 2016 up to NIS 50 million.
  • (3) Any net cash flow that will be received by the Company from the refinancing of the Radisson Blu hotel in Bucharest Romania up to €97 million shall not have repayment obligations, and shall be used by the Company at its sole discretion.

8. Significant events during the period (cont.)

D. Finding by PC with respect to certain agreements executed in the past:

In connection with the described in note 5 (C) and 14 C. (13) in the financial statement as of December 31, 2015, on March 29, 2016, PC has announced that its Board has become aware of certain issues with respect to certain agreements that were executed in the past by PC in connection with the Casa Radio Project in Romania. In order to address this matter, PC's Board has appointed the chairman of PC's Audit Committee to investigate the matters internally. PC's Board has also appointed independent law firms to perform an independent review of the issues raised. PC has approached and is co-operating fully with the relevant Romanian Authorities regarding the matters that have come to its attention in this respect and it has submitted its findings to the Romanian Authorities. As the investigation of this matter is ongoing PC in unable to comment on any details related to this matter. Following PC report to the Company, the Company's audit committee has appointed a special committee to examine the matters raised in PC's announcement, including any internal control and reporting issues. The Company is fully cooperating with the relevant governmental agencies in this matter. As of the date of the approval of the financial statements and at this preliminary stage, the Company, based on legal advice received, cannot estimate the potential consequences that the Company could incur as a result of these issues, and accordingly did not include a provision in these financial statements with respect to these issues.

E. Sale of Liberec Plaza:

On March 31, 2016, PC has completed the sale of its subsidiary holding Liberec Plaza, a shopping and entertainment center in the Czech Republic, for €9.5 million (NIS 40 million). Following net asset value adjustments related to the subsidiary's balance sheet, PC received net €9.37 million (NIS 40 million) and recorded a loss of €350 thousands (NIS 1,499).

F. Class action settlement:

In connection with the law suit described in note 14 (B) (1) in the financial statement as of December 31, 2015, on April 6, 2016, the Company and some other defendants (i.e: the Company's and Elscint's former directors and officers) have entered into a settlement agreement with the Plaintiffs in class action #1318/99 (Gadish v. Elscint et. al.) (the "Settlement"). The Settlement generally provides that in consideration of a total payment of NIS 46 million (approximately \$11.9 million) (a) the Hotels & Marina Transactions cause of action (as well as any other cause of action that is – or may be – directed against EI and its former directors and officers and to Elscint and its former directors and officers) shall be exhausted with respect to all of the defendants; and (b) all other causes of action shall be exhausted with respect to EI and its former directors and officers as well as with respect to Elscint and its former directors and officers.

The Company's share in the aforementioned compensation is NIS 4 million (approximately \$1 million) and the rest will be financed by the Company's D&O Insurance.

The Settlement is subject to its final approval by the court, without which it shall have no force or effect. The Settlement is also subject to the right of the insurer to terminate the Settlement under certain circumstances.

The approval of the settlement is subject to the court's approval and additional preconditions fulfilment as determined in the agreement.

8. Significant events during the period (cont.)

G. Agreement to sell Riga Plaza:

On May 16, 2016, PC's jointly controlled subsidiary, in which PC has a 50% stake, has entered into a business sale agreement with respect to the sale of Riga Plaza shopping and entertainment centre in Riga, Latvia, to a global investment fund. The agreement reflects a value for the business of approximately €93.4 million which is in line with the last reported book value.

The closing of the transaction is subject to several conditions precedent, all of which are expected to be fulfilled in the coming months.

In view of the above, PC has reclassified the Investment in the equity accounted investee, which holds Riga Plaza to as asset held for sale.

H. On May 24, 2016, InSightec Health Canada has approved InSightec's Exablate Neuro system for the treatment of essential tremor.

I. Development facility agreed for Belgrade Plaza (Visnjicka):

On June 21, 2016 PC has signed a €42.5 million loan agreement to support the development of Belgrade Plaza (Visnjicka) in the Serbian capital, Belgrade, from a consortium of banks led by the Hungarian bank OTP Bank Plc.

Belgrade Plaza is being developed on a 31,000 sqm plot of land owned by Plaza in Belgrade. Construction of the commercial center is already in advanced stages and it is on schedule to open in the first half of 2017. Belgrade Plaza, which is currently over 50% pre-let, will comprise approximately 32,000 sqm of Gross Lettable Area (GLA).

J. Sale of residential plot in Lodz, Poland:

On June 28, 2016, PC has signed an agreement for the sale of a 20,700 sqm plot of land in Lodz, Poland, to a residential developer, for €2.4 million. The conditional agreement will be followed by a transfer agreement which is expected to be signed by the end of August 2016.

On transfer, PC expects to receive an initial payment of €1.04 million, followed by €180,000 in November 2016, €220,000 in December 2016 and a final instalment of €0.96 million in June 2017.

K. Reverse share split:

On March 31, 2016 the annual general meeting of the Company shareholders approved the reverse split of its ordinary shares such that each 3 ordinary shares will be replaced to one ordinary share of the Company. The reverse spilt occurred on June 27, 2016 and the total number of Issued and outstanding ordinary shares following the reverse split is 9,190,808.

L. Closing of the sale of MUP plot in Belgrade by PC:

In June 29, 2016 PC has completed the sale of its wholly owned subsidiary, which holds the "MUP" plot and related real estate in Belgrade, Serbia, for €15.9 million and recorded a gain of € 2.4 million (NIS 10). the purchaser has paid the initial amount of €11 million (NIS 47) in cash to PC. An additional €300,000 (NIS 1,258,000) will be due before 30 November 2016 and the remaining €4.6 million (NIS 20 million) will be due within 15 months from the transaction closing date. Furthermore, PC will also be entitled to an additional pending payment of €600,000 (NIS 2,570,000), on top of the €15.9 million (NIS 68 million) transaction consideration, once the purchaser successfully develops at least 69,000 sqm above ground.

In line with PC's stated restructuring plan, 75% of the abovementioned proceeds will be distributed to Plaza's bondholders in the following quarter.

8. Significant events during the period (cont.)

M. Termination of lease agreement regarding land plot near Tiberius:

In connection with the described in note 9 (E) in the financial statement as of December 31, 2015, on June 23, 2016 the Company announced a termination of the lease agreement with the Israel Land Administration ("ILA").

Following the termination of the Agreement, ILA released two bank guarantees in the aggregated amount of approximately NIS 13 million, which have been provided to ILA in order to secure the Company's undertakings under the leasea greement and an additional amount of approximately NIS 7 million which have been received after the financial reports date.

At this stage, the Company cannot estimate if and when the Company will be entitled to receive any additional amounts following the termination of the Agreement.

N. Debt repayment agreement with financing bank of Zgorzelec PC shopping center in Poland:

On June 30, 2016, PC has signed a Debt Repayment Agreement ("DRA") with the financing bank (the "Bank") of Zgorzelec PLaza Shopping Center in Poland.

As part of the DRA, PC will make a payment of €1.1 million (in escrow) to the financing bank of the Shopping Center and the financing bank will deposit (in escrow) Release Letters for: (i) releasing a mortgage in favor of the Bank on PC's plot in Leszno, Poland; (ii) releasing of a recourse right obligation (of €1.1 million) under PC's corporate guarantee and an additional subsidiary of PC; (iii) subordination agreement; and (iv) submission for enforcement on the loan.

The DRA also states that PC is obliged to make its best effort and cooperate with the Bank in trying to sell Zgorzelec Plaza Shopping Center. Simultaneous with this, the financing bank will seek a third party to be an appointed shareholder to purchase the shares of Zgorzelec Plaza Shopping Center for €1.

If a buyer or appointed shareholder is not found by 15 September 2016 the following steps will take place: The management of Zgorzelec Plaza Shopping Center will be transferred to an appointed manager elected by the Bank; The €1.1 million payment held in escrow will be transferred to the Bank; and the Release Letters will be given to PC and PC will stay as a silent shareholder in Zgorzelec Plaza Shopping Center until the end of the 2016.

On conclusion of the transaction, PC expects to lose its control over the project company holding Zgorzelec Shopping Center which will result in de-recognition of the assets and liabilities of the former subsidiary from the consolidated statement of financial position and recognizing a gain of approximately €10 million.

O. Update on Bangalore project - India:

In connection with the described in note 7 (A) in the financial statement as of December 31, 2015: The National Green Tribunal ("NGT"), an Indian governmental tribunal established for dealing with cases relating to the environment, passed general directions on May 04, 2016 with respect to areas that should be treated as "no construction zones" due to its proximity to water reservoirs and water drains ("Order")

The restrictions in respect of the "no construction zone" are applicable to all construction projects.

The government of Karnataka had been directed to incorporate the above conditions in respect of all construction projects in the city of Bangalore including the Company's project which is adjacent to the Varthur lake and have several storm-water crossing it.

An appeal was filed before the Supreme Court of India against the Order. The Supreme Court has stayed the operation of certain portions of the Order. It is difficult to predict the amount of time that the Supreme Court of India will take to decide on the matter.

8. Significant events during the period (cont.)

O. Update on Bangalore project – India (cont.):

Accordingly, the impact of the Order cannot be fully determined until the Supreme Court of India adjudicates upon the matter. It should also be noted that based on the Company legal advice, the Order only affects the setback from the storm-water drain, and would not in itself affect the floor space index available to developers to construct a project.

As for June 30, 2016 and to the Company's best estimate that there will be no material effect on the Company's consolidated financial statements as a result of the Order.

P. Update on PC covenants:

In respect of the Coverage Ratio Covenant ("CRC"), as defined in PC restructuring plan, as at June 30, 2016 the CRC was 126%, in comparison with 118% minimum ratio required.

9. Subsequent events

A. Ruling of the international court of arbitration:

In connection with the described in note 14 C. (8) in the financial statement as of December 31, 2015, in July 2016, following an extensive and lengthy legal procedure relating to a transaction agreement undertaken between PC, and Klepierre in 2004, the International Court of Arbitration has ruled that PC is liable for an indemnification claim totaling approximately €2 million (NIS 9 million), including costs arising from the legal process. A provision for such amount has been initially recorded in these financial statements. Since Klepierre is deemed a creditor under PC's ongoing Restructuring Plan, payment of the principal amount due by PC under the indemnification claim is deferred to July 2018. In the interim, PC will continue to pursue the legal channels available to it in purpose to minimize the basis for such indemnification. The Company is a guarantor of PC under the original transaction agreement between PC and Klepierre executed in 2004.

B. FDA Approval of InSightec's Exablate neuro for treatment of essential tremor:

In July 2016 the FDA has approved InSightec's Exablate Neuro system for a non-invasive treatment of essential tremor (ET) in patients who have not responded to medication.

Exablate Neuro uses focused ultrasound waves to precisely target and ablate tissue deep within the brain with no incisions or implants. The treatment is done under Magnetic Resonance Imaging (MRI) guidance for real time treatment monitoring.

Essential tremor is the most common movement disorder, affecting more than 5 million people in the United States, and millions more worldwide. Hand tremor is the most common symptom, but tremors can also affect the head, arms, voice, legs, and torso. For these patients, performing everyday tasks presents a challenge and impacts their quality of life.

C. In July, 2016 the company purchased NIS 10.7 million serise H par value, for a total consideration of NIS 10 million.

D. Details of negotiations on two assets disposal in Poland:

At the end of July 2016 PC signed a non-binding Letter of Intent ("LOI") with a global investment fund (the "Purchaser") regarding the sale of the Torun Plaza and Suwałki Plaza shopping and entertainment centres in Poland (together the "Portfolio").

The Portfolio comprises a total of approximately 60,000 sqm of Gross Lettable Area, of which Torun Plaza represents approximately 40,000 sqm and Suwalki Plaza represent approximately 20,000 sqm. The total agreed value of the Portfolio is €121 million (NIS 518 million), subject to adjustments on the basis of the in place net operating income (the "NOI") and future NOI.

The sale is currently expected to complete by the end of October 2016.

9. Subsequent events (cont.)

D. Details of negotiations on two assets disposal in Poland (cont.):

Under the terms of the LOI, the Portfolio will remain under Plaza's management until December 31, 2017, during which time Plaza will continue to implement its asset management plans to further optimize the tenant mix and improve the rental income and the NOI.

At this stage, there is no certainty that the transaction will be completed.

E. Joint development agreement signed in respect of plot in Chennai, India:

On August 2, 2016, a subsidiary ("SPV") of Elbit Plaza India Real Estate Holdings Limited (in which the Company holds a 50% stake with its subsidiary, Plaza Centers N.V) ("EPI"), has signed a Joint Development Agreement ("JDA") relating to its 74.7 acre plot in Chennai, India.

Under the terms of the JDA, the SPV will confer the property development rights to a reputable local developer (the "Developer") who will carry full responsibility for all of the project costs and liabilities, as well as for the marketing of the scheme. The JDA also stipulates specific project milestones, timelines and minimum sale prices.

E. Joint development agreement signed in respect of plot in Chennai, India (cont.):

Development will commence subject to the obtainment of the required governmental/ municipal approvals and permits, and it is intended that 67% of the land will be allocated for the sale of plotted developments (whereby a plot is sold with the infrastructure in place for the development of a residential unit by the end purchaser), while the remainder will comprise residential units fully constructed for sale.

The SPV will receive 73% of the total revenues from the plotted development and 40% of the total revenues from the sale of the fully constructed residential units.

In order to secure its obligation, the Developer will pay a total refundable deposit of INR 35.5 Crores (approximately €4.8 million), with INR 10 Crores (approximately €1.35 million) paid following the signing and registration of the JDA, INR 17 Crores (approximately €2.3 million) payable when planning permission for the first phase of the development project is obtained (the "Project Commencement Date"), and the remaining INR 8.5 Crores (approximately €1.15 million) payable six months after the Project Commencement Date.

In line with its statement in the 2015 year-end financial statements, EPI continues its efforts to exercise its right to get the Partners' 20% holding in the Indian company Kadavanthara Builders Private Ltd.

F. Insightec has signed a cooperation agreement with Siemens

On August 15, 2016, INSIGHTEC has signed a non-exclusive cooperation agreement with Siemens Healthcare GmbH ("Siemens"), a leading manufacturer and developer of diagnostic imaging equipment in general and Magnetic Resonance scanners specifically, to develop compatibility between INSIGHTEC's MRI guided Focused Ultrasound Systems (MRgFUS) and Siemens MRI scanners (the "Systems") with the intention to expand the MRgFUS market globally (the "Agreement"). According to the Agreement, the Parties will cooperate regarding the performance of R&D, integration, testing and approving the compatibility of the Parties' Systems. Each Party shall be solely responsible, at its own cost, to obtain the regulatory approval for its systems, and InSightec shall be solely responsible, at its sole cost, to obtain the regulatory approval for the combined system. Each Party shall bear all of its internal and external costs relating to its performance under the Agreement, except that InSightec shall reimburse Siemens an amount agreed upon in the Agreement, for its R&D costs. The Agreement also determines that each Party shall act independently in the marketing and sales of its component portion of the Combined System, and determines the amount InSightec shall pay Siemens for sales of the Combined Systems. The term of the Agreement is five (5) years from the first commercial sale of the combined system and shall automatically renew for additional 1-year periods, unless either Party has provided a notice for its non-renewal or of its termination, it in accordance with the terms of the Agreement. Each Party shall have a limited liability towards the other Party for direct damages only. In addition, each Party is required to maintain a minimal insurance coverage for the purpose of the Agreement during the term of the Agreement and for a few years thereafter.

G. Nots buyback programs by the Company

On August 18, 2016, the Company announced that its board of directors approved a new program to repurchase up to NIS fifty (50) million (approximately \$13.26 million) of Elbit's Notes, which are traded on the Tel Aviv Stock Exchange in addition to the Current Program ("The New Program") (see note 8 A). The Company's board of directors has determined that until further notice, the Company will purchase only Series H Notes under the New Program. The repurchases will commence after the full execution of the Current Program, and the New Program will remain in effect for a period of 12 months commencing on the date of this announcement.

In accordance with the existing loan agreement with Bank Hapoalim (as amended), the Company will be required to prepay principal amount of approximately NIS 7 million if the Notes buyback under the New Program will be fully executed.

Talk to a Data Expert

Have a question? We'll get back to you promptly.